Prosecution Insights
Last updated: November 04, 2026
Application No. 18/531,829

POLYCARBONATE OLIGOMER, MANUFACTURING METHOD THEREOF, CURABLE COMPOSITION, EPOXY CROSSLINKED PRODUCT, AND METHOD FOR DEGRADING EPOXY CROSSLINKED PRODUCT BY AMINOLYSIS

Non-Final OA §103
Filed
Dec 07, 2023
Priority
Dec 09, 2022 — TW 111147351
Examiner
ROSEBACH, CHRISTINA H.W.
Art Unit
1766
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Swancor Innovation & Incubation Co., Ltd.
OA Round
1 (Non-Final)
59%
Grant Probability
Moderate
1-2
OA Rounds
2m
Est. Remaining
25%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
276 granted / 467 resolved
-5.9% vs TC avg
Minimal -34% lift
Without
With
+-34.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
22 currently pending
Career history
496
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
58.0%
+18.0% vs TC avg
§102
12.3%
-27.7% vs TC avg
§112
22.3%
-17.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 467 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I claims 1, 6-9 and the species polycarbonates with only oxygen heteroatoms in the reply filed on 8/19/26 is acknowledged. The traversal is on the ground(s) that the office has not provided an alternative process by which group I’s asymmetrically terminated oligomer could be produced. This is not found persuasive because polymerization of polycarbonate monomers to oligomers is perfectly capable of providing asymmetrically terminated polycarbonates, see for example CN 107090080 by Yin et al (translation- abstract and paragraph 5 Formula 4). The requirement is still deemed proper and is therefore made FINAL. Claims 5-8, 10-13 withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 8/19/26. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1 and 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over WO 2020075611 by Ozaki et al. Ozaki describes an epoxy resin composition. Regarding claim 1, Ozaki describes a polycarbonate oligomer with the formula: PNG media_image1.png 144 649 media_image1.png Greyscale In this formula, Ozaki’s terminal phenyl group reads on instant formula (I) when instant R2 is formula (1), and Ozaki’s X significantly overlaps with instant formula (I)’s X, Ozaki’s Rs significantly overlap with instant Rs (translation p.3 penultimate paragraph). It would be obvious to one of ordinary skill to arrive at the instant invention given Ozaki’s disclosure because Ozaki describes many embodiments which overlap with the instant structure. Regarding claim 9, temperature of mixing is a product-by-product phrase. “[E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process.” In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985). Since Ozaki describes the product, a curable composition, Ozaki meets the claim. Notably the claim phrasing includes temperature values which are typically below the softening points of polycarbonate oligomers and epoxy resins. Claims 6 and 7 are rejected under 35 U.S.C. 103 as being unpatentable over WO 2020075611 by Ozaki et al as evidenced by “Epoxy Resins” by Pham et al. Ozaki is described above. Regarding claim 6, Ozaki describes a curable composition comprising the polycarbonate oligomer, epoxy resin (p.1 final paragraph) and catalyst and curing accelerator (p.12 paragraph 2). Notably Pham states that some curing accelerators described by Ozaki (for example tertiary amines) “act as a catalyst to accelerate epoxy reactions” (p.392 final paragraph). Ozaki uses a ratio of epoxy group to hydroxyl group and carbonic acid ester group of 0.5 to 10 (p.13 paragraph 2), or 0.1-2 in the instant terms. Ozaki describes mixing without temperature description, i.e. at room temperature (p.13 paragraph 3). Regarding claim 7, Ozaki describes 2-methylimidazole, 2-phenylimidazole, 2-ethyl-4-methylimidazole, and imidazole (p.12 paragraph 2). Even if Ozaki describes these elements in terms of a different action besides catalysis, a chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. See MPEP 2112.01(I) , In re Best, 562 F2d at 1255, 195 USPQ at 433, Titanium Metals Corp v Banner, 778 F2d 775, 227 USPQ 773 (Fed Cir 1985), In re Ludtke, 441 F2d 660, 169 USPQ 563 (CCPA 1971) and Northam Warren Corp v D F Newfield Co, 7 F Supp 773, 22 USPQ 313 (EDNY 1934). Since Ozaki describes these chemical additives as present, they meet the claim language of “catalyst”. Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over WO 2020075611 by Ozaki et al as evidenced by “Epoxy Resins” by Pham et al in view of US 4782124 by Hefner et al. Ozaki is described above. Regarding claim 8, Ozaki is silent as to the amount of catalyst or curing accelerator added, but does describe their general presence (p.12 paragraph 2). Hefner, like Ozaki, describes creating an epoxy resin modified by polycarbonate oligomer (Hefner abstract). Hefner describes an amount of 0.001-1% of a catalyst based on the weight of epoxy (col 6 ln 25-30). Hefner states that this results in advancing the reaction between a vicinal epoxy and phenolic hydroxyl group (col 6 ln 22-27). Thus it would be obvious to one of ordinary skill to use the catalyst and amount described by Hefner where Ozaki is silent because it is effectual in advancing the reaction between epoxy and phenolic hydroxyl. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTINA W ROSEBACH whose telephone number is (571)270-7154. The examiner can normally be reached 8am-3:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached at 5712721302. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHRISTINA H.W. ROSEBACH/Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

Dec 07, 2023
Application Filed
Jun 18, 2026
Response after Non-Final Action
Oct 30, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12774377
EVERGREEN UPCYCLING PROCESS FOR THERMOSETS AND THERMOPLASTICS WITH DECONSTRUCTABLE AND UPGRADABLE MONOMERS
3y 6m to grant Granted Oct 27, 2026
Patent 12766477
HEAT-EXPANDABLE MICROSPHERES, PROCESS FOR PRODUCING THE SAME, AND APPLICATION THEREOF
4y 1m to grant Granted Oct 20, 2026
Patent 12767780
DEPOLYMERIZATION OF POLYURETHANES FOR CIRCULAR ECONOMY PLASTICS
3y 4m to grant Granted Oct 20, 2026
Patent 12759214
BIAXIALLY ORIENTED POROUS MEMBRANES, COMPOSITES, AND METHODS OF MANUFACTURE AND USE
9y 5m to grant Granted Oct 13, 2026
Patent 12760162
PEI or PEI-PEEK particle foams for applications in lightweight construction
4y 0m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
59%
Grant Probability
25%
With Interview (-34.3%)
3y 1m (~2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 467 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month